HEARTWARE VENTRICULAR ASSIST SYSTEM
Medtronic · Decision date Nov 20, 2012
What did the FDA approve?
FDA records P100047 as an original PMA application. The recorded decision is approval, dated Nov 20, 2012.
FDA approval order statement
APPROVAL FOR THE HEARTWARE VENTRICULAR ASSIST SYSTEM (VAS). THIS DEVICE IS INDICATED FOR USE AS A BRIDGE TO CARDIAC TRANSPLANTATION IN PATIENTS WHO ARE AT RISK OF DEATH FROM REFRACTORY END-STAGE LEFT VENTRICULAR HEART FAILURE. THE HEART WARE VAS IS DESIGNED FOR IN-HOSPITAL AND OUT-OF-HOSPITAL SETTINGS, INCLUDING TRANSPORTATION VIA FIXED WING AIRCRAFT OR HELICOPTER.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Nov 20, 2012
Regulatory record facts
- Identifier
- P100047
- Regulatory pathway
- Premarket approval application
- Applicant
- Medtronic
- Product code
- DSQ
- Decision code
- APPR
- Decision date
- Nov 20, 2012
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Ventricular (assist) bypass.
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P100047 received
Application receipt date recorded by FDA.
P100047 · FDA decision
APPR
P100047/S241 · Related supplement
HeartWare HVAD System
Timeline entries are records held by MedtechLedger for P100047. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P100047
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
HeartWare HVAD SystemP100047/S241 | Medtronic | PMA supplement | Sep 23, 2026 | FDA |
Explore the linked device profile
Other records with product code DSQ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EXCOR Pediatric Ventricular Assist DeviceP160035/S054 | Berlin Heart, Inc. | PMA supplement | Oct 30, 2026 | FDA |
CentriMag Circulatory Support SystemP170038/S034 | Abbott | PMA supplement | Oct 30, 2026 | FDA |
EXCOR Pediatric VADP160035/S061 | Berlin Heart, Inc. | PMA supplement | Oct 28, 2026 | FDA |
EXCOR Pediatric Ventricular Assist DeviceP160035/S060 | Berlin Heart, Inc. | PMA supplement | Oct 23, 2026 | FDA |
HeartMate 3 Left Ventricular Assist SystemP160054/S136 | ABBOTT MEDICAL | PMA supplement | Oct 19, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 8200 Coral Sea St. N.E, Mounds View, MN, 55112
Sources and methodology
- Original FDA record: P100047
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



